Company Genetic Signatures Limited

Equities

GSS

AU000000GSS4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:13:32 2024-05-30 am EDT 5-day change 1st Jan Change
0.73 AUD -.--% Intraday chart for Genetic Signatures Limited -.--% +67.82%

Business Summary

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company’s principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit and others.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Reagents and Consumables
97.4 %
34 96.1 % 16 97.4 % -51.53%
Equipment Sales and Rental
2.6 %
1 3.3 % 0 2.6 % -61.88%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
82.5 %
28 79.4 % 14 82.5 % -50.30%
EMEA
9.4 %
4 10.8 % 2 9.4 % -58.62%
Asia Pacific
8.2 %
3 9.8 % 1 8.2 % -60.23%

Managers

Managers TitleAgeSince
Director of Finance/CFO - 23-06-25
Chief Tech/Sci/R&D Officer - 01-02-14
Director/Board Member 64 14-01-01
General Counsel - 01-12-31
Corporate Officer/Principal - 16-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 15-09-14
Director/Board Member - 22-05-12
Director/Board Member 64 14-01-01
Chairman - 07-12-31
Director/Board Member - Dec. 03
Chief Executive Officer 63 21-04-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 186,482,642 134,456,857 ( 72.10 %) 0 72.10 %

Shareholders

NameEquities%Valuation
38,392,200 20.59 % 17 M $
Perennial Value Management Ltd.
12.50 %
23,315,814 12.50 % 11 M $
FIL Investment Management (Hong Kong) Ltd.
6.022 %
11,230,653 6.022 % 5 M $
Regal Funds Management Pty Ltd.
4.979 %
9,284,395 4.979 % 4 M $
Pengana Capital Ltd.
3.450 %
6,434,451 3.450 % 3 M $
Capital Concerns Pty Ltd.
1.757 %
3,276,134 1.757 % 1 M $
2,072,171 1.111 % 935 171 $
Braham Consolidated Pty Ltd.
1.004 %
1,871,966 1.004 % 844 818 $
John Melki
0.6761 %
1,260,813 0.6761 % 569 005 $
Riddler Family Investments Pty Ltd.
0.5786 %
1,078,919 0.5786 % 486 916 $

Company contact information

Genetic Signatures Ltd.

7 Eliza Street

2042, Newtown

+

http://www.geneticsignatures.com
address Genetic Signatures Limited(GSS)
  1. Stock Market
  2. Equities
  3. GSS Stock
  4. Company Genetic Signatures Limited